MediWound Announces 16.25 Million Funding from the European Innovation Council Accelerator Program
| MDWD Stock | USD 16.90 0.43 2.48% |
About 61% of Mediwound's investor base is looking to short. The analysis of overall sentiment of trading Mediwound stock suggests that many investors are alarmed at this time. The current market sentiment, together with Mediwound's historical and current headlines, can help investors time the market. In addition, many technical investors use Mediwound stock news signals to limit their universe of possible portfolio assets.
Mediwound |
Funds to be used for clinical development of EscharEx to treat diabetic foot ulcers Award advances MediWounds DFU program and its future revenues four years ahead of original schedule YAVNE, Israel,
Read at benzinga.com
 |
Mediwound Fundamental Analysis
We analyze Mediwound's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mediwound using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mediwound based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Mediwound is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Mediwound Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mediwound stock to make a market-neutral strategy. Peer analysis of Mediwound could also be used in its relative valuation, which is a method of valuing Mediwound by comparing valuation metrics with similar companies.
Peers
Mediwound Related Equities
| CTMX | CytomX Therapeutics | 6.25 | ||||
| ASMB | Assembly Biosciences | 2.63 | ||||
| SLNO | Soleno Therapeutics | 1.96 | ||||
| CAPR | Capricor Therapeutics | 1.28 | ||||
| CRNX | Crinetics Pharmaceuticals | 1.21 | ||||
| ACHL | Achilles Therapeutics | 0.94 | ||||
| MBRX | Moleculin Biotech | 1.13 | ||||
| BPTH | Bio Path | 2.44 | ||||
| TIL | Instil Bio | 2.83 |
Complementary Tools for Mediwound Stock analysis
When running Mediwound's price analysis, check to measure Mediwound's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mediwound is operating at the current time. Most of Mediwound's value examination focuses on studying past and present price action to predict the probability of Mediwound's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mediwound's price. Additionally, you may evaluate how the addition of Mediwound to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |